Package 24979-210-04

{"route": ["ORAL"], "spl_id": "bf831629-b5b8-41c4-9e1c-a5e6e5532144", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0324979211046"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316"], "spl_set_id": ["e0d88f34-865c-441b-80e2-e814c9a7d670"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 PACKAGE (24979-210-04)", "package_ndc": "24979-210-04", "marketing_start_date": "20231205"}], "brand_name": "Topiramate", "product_id": "24979-210_bf831629-b5b8-41c4-9e1c-a5e6e5532144", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "24979-210", "generic_name": "Topiramate", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "15 mg/1"}], "application_number": "ANDA217694", "marketing_category": "ANDA", "marketing_start_date": "20231205", "listing_expiration_date": "20261231"}